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Supraventricular
Tachyarrhythmias : Not Always
So Benign*
JEFFREY L . ANDERSON, MD, FACC
Salt Lake City. Utah
Introduction and perspective . Supraventricular tachyar-
rhythmias affect >2 million Americans
(1) .
Marketing sur-
veys indicate that antiarrhythmic therapy is given for symp-
tomatic supraventricular arrhythmias at least as frequently
as for ventricular arrhythmias . Yet, until recently, little
attention has been paid to these presumably benign arrhyth-
miss (2). In contrast, management of aborted sudden cardiac
death has long focused on ventricular arrhythmia mecha-
nisms (3-5) . Given the high rate of recurrence of cardiac
arrest, aggressive strategies have been developed, including
use of the implantable cardioverter-defibrillator (lCD) (6) .
With recognition that noninducibility of ventricular tachyar-
rhythmia at electrophysiologic study does not guarantee a
low risk of recurrence, guidelines now allow for ICD implan-
tation even in patients with noninducible arrhythmia . As of
July 8, 1991, the Health Care Financing Administration no
longer requires electrophysiologic inducibility for coverage
of ICD implantation and has removed the condition that such
therapy be a treatment of last resort (7) . These new guide-
lines not only allow ICD application in a broader group of
patients at risk but also may tempt physicians to ovenitilize
the ICD in the belief that, whatever the arrest mechanism,
the ICD will be protective . The present study by Wang et al .
(8) in this issue of the Journal suggests that there is a group
of patients in whom the mechanism of ventricular fibrillation
induction is a rapidly conducting supraventricular tachyar-
rhythmia, and in whom treatment of the tachyarrhythmia,
rather than lCD implantation, is appropriate
.
The present study . The present study (8) describes 13
(4 .5%) of
290 patients presenting for electrophysiologic
study with a history of aborted sudden death . In these 13
patients, the initiating mechanism of cardiac arrest was
documented or inferred to be a supraventricular tachyar-
rhythmia . As expected, many (six) patients had a rapid,
anterogradely conducting accessory connection, a well
known substrate for ventricular fibrillation in patients with
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the Wolff-Parkinson-White syndrome (9,10) . However, of
great interest were the other mechanisms, including atria-
ventricular (AV) node reentry and atria) fibrillation with
enhanced AV conduction . Of further interest was the obser-
vation that treatment directed at preventing the supraven-
tricular lachyarrhythmia was associated with an excellent
prognosis.
Although the study was retrospective in nature, the
authors (8) were conservative in their selection of patients,
excluding those patients (n = 27, 9.3%) who also had an
inducible ventricular tachyarrhythmia or in whom the su-
praventricular tachyerrhythmia substrate (for example, AV
node reentry, aerial tachycardia, enhanced AV node conduc-
tion) was not shown to cause hemodynantic compromise .
Inclusion of a patient required monitored documentation of
spontaneous supraventricular tachyarrhythmia preceding
ventricular fibrillation (n = 7), or induction of supraventric-
ular tachyarrhythmia demonstrating hemodyn3mic instabil-
ity and requiring prompt termination, or both (n = 10) .
Because aggressive pacing techniques for induction of atria]
fibrillation, including isoproterenol infusion, were not used
in all patients, it seems likely that a greater rather than a
smaller percent of patients who had cardiac arrest may have
had a precipitating supraventricular tachyarrhythmia mech-
anism.
Caveats and interpretations . Supraventricular tachyar-
rhythmia mechanisms of aborted sudden death are of three
types. The first, the Wolff-Parkinson-White syndrome, has
r-ceived much attention and is most likely to be correctly
s .tagnosed and treated (9-I1). The other mechanisms, AV
node reentry (12,13) and accelerated conduction of atrial
fibrillation (14-16), have been discussed only in anecdotal
reports. Although the patient groups are quite small, the
experience presented may be prototypic . Those with AV
node reentry generally did not have associated coronary
artery or other structural heart disease, whereas those with
atrial fibrillation were older and did have significant struc-
tural and associated electrical disease . In one patient, anti-
arrhythmic therapy (flecainide) was suspected to have a
proarrhythmic effect
(17) . Subtle abnormalities of AV con-
duction (atrio-Hisian or atriofascicular pathway connec-
tions) were found in two patients . An tCD was implanted in
four patients but it was ineffective or not used, or it compli-
cated therapy (by repeated discharges without effective
arrhythmia termination)
. In contrast, each patient receiving
appropriate therapy directed at the supraventricular tachyar-
rhythmia had a benign course . (The one death was unrelated
to arrhythmia
.) Effective treatments included catheter or
surgical ablation of accessory pathways in patients with
Wolff Parkinson-White syndrome, drug therapy or .atheter
modification in patients with AV node reentry and drug
therapy with or without catheter ablation of the AV junction
and pacemaker insertion in patients with atria) fibrillation
and accelerated AV junction conduction .
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Study limitations . Important limitations of the study in-
clude its retrospective
nature and the small number of
patients . However, the experience does add substantially to
the few cases previously reported
(12-17) and is denied
from a large denominator of patients .
The relafmo iedlween
arrhythmias and ventricular fibrillation teas not directly
documented in six patients
; rather, it was but inferred front
findings in the electrophysiologic laboratory
. The use of
isoproterenol to induce and facilitate atria) fibrillation raises
questions of specificity, as it has in its application for
ventricular .. .anythmias . However, in patients with docu-
mented clinical events the predictive accuracy of induced
atrial fibrillation is likely to be much greater than in groups of
patients without prior events . One may quibble over the
inclusion of the patient with hypertrophic cardiomyopathy, a
condition in which ventricular arrhythmias are variably
inducible. and of the patient whose ventricular fibrillation
was ascribed to a pre'rrhythmic effect of flecainide (17) . On
the whole, however, one is persuaded that a supraventricu-
lar tachyarrhythmia mechanism may be at least as frequent a
cause of cardiac arrest as the authors report
(8) .
Implications . The present study should increase aware-
ness of supraventricular tachyarrhythmia as a possible pre-
cipitating mechanism of aborted sudden death and focus
attention on this mechanism for future study
. This recogni-
tion should lead to reassessment of electrophysiologic pro-
tocols for evaluating aborted sudden death in patients,
particularly when ventricular tachyarrhythmias are not in-
duced
. Specifically, an aggressive induction protocol for
atrial fibrillation is suggested, perhaps focusing on patients
with rapid AV conduction (short AV block cycle length or
short AV node effective refractory period) . In specific cases .
facilitated AV node conduction may relate to paranodal
bypass pathways, including atrio-Hisian or atriofascicular
connections (18) .
Recognizing these mechanisms may lead
to more specific, directed therapy. Furthermore . it may be
important to evaluate in future studies possible interactions
between suprav°ntricular and ventricular mechanisms (both
were present in 9 .3% of their patients. but these patients
were excluded from the analysis). Finally, the study illus-
trates a limitation of use of the ICD in survivors of sudden
death in whom ventricular arrhythmias are not induced . As
noted here, such therapy is often ineffective for converting
supraventricular tachyarrhythmia and may even have ad-
verse effects, conceivably inducing ventricular fibrillation .
Conclusions . These cases suggest That supraventricular
lachyarrhythmia may not always be as benign as generally
perceived. Patients with aborted sudden cardiac death
should be more carefully screened for the possibility that
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their cardiac arrest may have been triggered by a supraven .
tricolor tachyarrhythmia.
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